uniQure (QURE) Exchange Rate Effect (2016 - 2026)
uniQure (QURE) posted quarterly Exchange Rate Effect of -$774000.0 for Q2 2026, down 122.82% year-over-year from $3.4 million in Q2 2025, and up 31.63% quarter-over-quarter from -$1.1 million in Q1 2026.
Powered by 
Analysis
uniQure (QURE) Exchange Rate Effect (2016 - 2026) Analysis & Trends
uniQure's Exchange Rate Effect history runs 11 years deep, the most recent figure standing at -$774000.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 122.82% year-over-year to -$774000.0; the TTM figure through Jun 2026 stood at -$1.3 million (down 157.21% YoY), while the FY2025 annual figure was $5.7 million, up 213.85% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at -$774000.0, up from -$1.1 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $10.0 million in Q4 2022, with the low at -$6.8 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$361500.0 (2024), against an average of -$43555.6.
- Peak annual rise in Exchange Rate Effect reached 960.02% in 2022, while the deepest fall reached 9264.44% in 2022.
- uniQure's Exchange Rate Effect stood at $10.0 million in 2022, then sank by 81.67% to $1.8 million in 2023, then plunged by 467.46% to -$6.8 million in 2024, then surged by 96.2% to -$257000.0 in 2025, then slumped by 201.17% to -$774000.0 in 2026.
- Business Quant data shows QURE's Exchange Rate Effect at -$774000.0 in Q2 2026, -$1.1 million in Q1 2026, and -$257000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | -774,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -774,000.00 |
| Mar 31, 2026 | -1.13 Mn |
| Dec 31, 2025 | -257,000.00 |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | -6.77 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Jun 30, 2024 | -466,000.00 |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | -1.39 Mn |
| Jun 30, 2023 | 778,000.00 |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 10.05 Mn |
| Sep 30, 2022 | -6.49 Mn |
| Jun 30, 2022 | -4.21 Mn |
| Mar 31, 2022 | -1.17 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | -924,000.00 |